High-sensitivity c-reactive protein as a predictor of de novo atrial fibrillation in dyslipidemia patients treated with moderate-intensity statin
28 August 2016 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker

Sejong general hospital, Seoul (Korea (Republic of))
14 More presentations in this session
Access the full session
The Event
ESC Congress 2016
28 August 2016
08:30 CET
